PMID: 9525639Apr 3, 1998Paper

Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis

Journal of Virology
M S KraftE Meinl

Abstract

Herpesvirus saimiri (HVS) transforms human T cells to stable growth in vitro. Since HVS codes for two different antiapoptotic proteins, growth transformation by HVS might be expected to confer resistance to apoptosis. We found that the expression of both viral antiapoptotic genes was restricted to cultures with viral replication and absent in growth-transformed human T cells. A comparative examination of HVS-transformed T-cell clones and their native parental clones revealed that the expression of Bcl-2, Bcl-X(L), Bax, and members of the tumor necrosis factor receptor (TNF-R) superfamily with a death domain, namely, TNF-RI, CD95, and TRAMP, were not modulated by HVS. Expression of CD30 was induced in HVS-transformed T cells, and these cells also expressed the CD30 ligand. Uninfected and transformed T cells were sensitive to CD95 ligation but resistant to apoptosis mediated by TRAIL or soluble TNF-alpha. CD95 ligand was constitutively expressed on transformed but not uninfected parental T cells. Both cell types showed similar sensitivity to cell death induction or inhibition of T-cell activation mediated by irradiation, oxygen radicals, dexamethasone, cyclosporine, and prostaglandin E2. Altogether, this study strongly suggests t...Continue Reading

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·B BiesingerB Fleckenstein
Sep 1, 1992·The Journal of Experimental Medicine·H W MittrückerB Fleischer
Jan 1, 1992·Annual Review of Immunology·N H Sigal, F J Dumont
Jan 1, 1992·Annual Review of Immunology·J J CohenK S Sellins
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P J AustinS H Speck
Oct 22, 1993·Cell·D M HockenberyS J Korsmeyer
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·F WeberR Hohlfeld
Oct 1, 1994·AIDS Research and Human Retroviruses·K F CopelandJ L Heeney
Sep 1, 1995·The Journal of Biological Chemistry·J U JungB Biesinger
Jan 1, 1995·Annual Review of Immunology·S Cory
Dec 11, 1994·Nucleic Acids Research·M HerrmannJ R Kalden
Feb 1, 1995·Immunology Today·E MeinlB Fleckenstein
Mar 1, 1996·Nature Medicine·M TanakaS Nagata
Mar 1, 1996·The Journal of Biological Chemistry·A M ChinnaiyanV M Dixit
Nov 28, 1996·Nature·J KitsonS N Farrow
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·J BertinJ I Cohen
Apr 4, 1997·Science·G PanV M Dixit
May 1, 1997·Journal of Virology·V E NavaJ M Hardwick
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·G R ScreatonJ I Bell
Dec 31, 1997·FEBS Letters·P SchneiderJ Tschopp

❮ Previous
Next ❯

Citations

Sep 21, 2004·Oncogene·Gültekin TamgüneyHelmut Fickenscher
Sep 25, 2004·Journal of Cellular Physiology·Alexander Y Tsygankov
Nov 5, 1999·Annual Review of Microbiology·A RoulstonP E Branton
Apr 21, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·H Fickenscher, B Fleckenstein
Feb 25, 2005·Journal of Leukocyte Biology·José M Martín-FernándezJosé R Regueiro
May 18, 2000·Reviews in Medical Virology·S Mittnacht, C Boshoff
Sep 6, 2001·European Journal of Immunology·G HenningE Meinl
Mar 18, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·R ChiarleG Inghirami
Feb 16, 2000·Journal of Neuroimmunology·E Meinl, R Hohlfeld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.